| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.54 | 0.06 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.38 | 0.04 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.19 | 9e-06 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |